2 completed, 1 suspended. 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Suspended 1 |
Follow Anji Pharma: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1 Study of ANJ900 Chinese Healthy Subjects ANJ900, Metformin IR - Healthy | Phase 1 | Completed | Anji Pharma | 18 | 2021-10-15 | 2022-06-08 |
| Investigational Study of Delayed Release Metformin Metformin DR, Metformin IR, Metformin DR Placebo - Diabetes Mellitus, Type 2 | Phase 3 | Suspended | Anji Pharma | 675 | 2021-05-18 | 2023-03-14 |
| A Proof of Concept Study of Pradigastat in Patients With Functional Constipation Pradigastat Tablets 20mg, Pradigastat Tablets 40mg, Pradigastat Tablets 20mg matching Placebo - Functional Constipation | Phase 2 | Completed | Anji Pharma | 181 | 2020-09-22 | 2022-08-24 |
pradigastat (1)
China (2) · United States (2) · Brazil (1) · Bulgaria (1) · Canada (1) · Czechia (1) · Hungary (1) · Poland (1) · Spain (1)
Dan Meyers, M.D. (1) · Dan Meyers, MD (1) · Dongyang Liu, MD (1) · Haiyan Liu, MD (1)